Pluristem Therapeutics, Inc. (PSTI): Price and Financial Metrics
GET POWR RATINGS... FREE!
PSTI Stock Price Chart Interactive Chart >
PSTI Price/Volume Stats
| Current price | $1.50 | 52-week high | $4.55 |
| Prev. close | $1.50 | 52-week low | $1.31 |
| Day low | $1.46 | Volume | 96,100 |
| Day high | $1.53 | Avg. volume | 972,264 |
| 50-day MA | $1.80 | Dividend yield | N/A |
| 200-day MA | $2.22 | Market Cap | 48.52M |
Pluristem Therapeutics, Inc. (PSTI) Company Bio
Pluristem Therapeutics Inc. operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related technologies for the treatment of various ischemic and inflammatory conditions. The company was founded in 2001 and is based in Haifa, Israel.
Latest PSTI News From Around the Web
Below are the latest news stories about Pluristem Therapeutics Inc that investors may wish to consider to help them evaluate PSTI as an investment opportunity.
15 Worst Stock Picks of Cathie WoodIn this article, we discuss the 15 worst stock picks of Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to the 5 Worst Stock Picks of Cathie Wood. Cathie Wood, the chief ARK Investment Management, is often hailed as the champion of “disruptive innovation” at the stock market. […] |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayI hope you enjoyed the long weekend, but it's time to get back into investing with the biggest pre-market stock movers for Tuesday! |
PSTI, BLRX and BBIG among pre-market gainersMainz Biomed (MYNZ) +14%. Vinco Ventures (BBIG) +13%. Digital World Acquisition (DWACW) +11%. Pluristem Therapeutics (PSTI) +10% |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back, trader! |
Pluristem jumps on collaboration with Tnuva to develop cultured cell-based food productsPluristem Therapeutics (PSTI) and Tnuva Group, Israel’s largest food producer, announce the launch of an innovative collaboration to develop, manufacture and commercialize… |
PSTI Price Returns
| 1-mo | -14.29% |
| 3-mo | -11.24% |
| 6-mo | N/A |
| 1-year | -60.53% |
| 3-year | -77.60% |
| 5-year | -89.29% |
| YTD | 2.74% |
| 2021 | -79.35% |
| 2020 | 79.44% |
| 2019 | -50.13% |
| 2018 | -42.75% |
| 2017 | -3.50% |
Continue Researching PSTI
Want to do more research on Pluristem Therapeutics Inc's stock and its price? Try the links below:Pluristem Therapeutics Inc (PSTI) Stock Price | Nasdaq
Pluristem Therapeutics Inc (PSTI) Stock Quote, History and News - Yahoo Finance
Pluristem Therapeutics Inc (PSTI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...